Stay updated on Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:59:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision update: version v3.4.3 replaces the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:36.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: from v3.4.1 to v3.4.2; no core content or user-facing features were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T10:27:21.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.0 to v3.4.1, with no visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:00.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added a glossary display option and new labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and introduced a 'No FEAR Act Data' notice. The older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:00:30.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Deleted the Statistical Analysis Plan (2018-02-02, 2.35MB) and the Study Protocol (2020-06-08, 1.12MB) from the study documents.
    Difference
    19%
    Check dated 2026-01-21T03:23:37.000Z thumbnail image

Stay in the know with updates to Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.